258 related articles for article (PubMed ID: 34841220)
21. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.
Kaluzova M; Bouras A; Machaidze R; Hadjipanayis CG
Oncotarget; 2015 Apr; 6(11):8788-806. PubMed ID: 25871395
[TBL] [Abstract][Full Text] [Related]
22. Active targeting using HER-2-affibody-conjugated nanoparticles enabled sensitive and specific imaging of orthotopic HER-2 positive ovarian tumors.
Satpathy M; Wang L; Zielinski R; Qian W; Lipowska M; Capala J; Lee GY; Xu H; Wang YA; Mao H; Yang L
Small; 2014 Feb; 10(3):544-55. PubMed ID: 24038985
[TBL] [Abstract][Full Text] [Related]
23. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
24. Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide.
Lee C; Jeong H; Bae Y; Shin K; Kang S; Kim H; Oh J; Bae H
J Immunother Cancer; 2019 Jun; 7(1):147. PubMed ID: 31174610
[TBL] [Abstract][Full Text] [Related]
25. Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.
Sun X; Gao D; Gao L; Zhang C; Yu X; Jia B; Wang F; Liu Z
Theranostics; 2015; 5(6):597-608. PubMed ID: 25825599
[TBL] [Abstract][Full Text] [Related]
26. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
27. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.
Wang L; Zhong X; Qian W; Huang J; Cao Z; Yu Q; Lipowska M; Lin R; Wang A; Yang L; Mao H
J Magn Reson Imaging; 2014 Nov; 40(5):1071-81. PubMed ID: 25485347
[TBL] [Abstract][Full Text] [Related]
28. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody.
Ding N; Sano K; Kanazaki K; Ohashi M; Deguchi J; Kanada Y; Ono M; Saji H
Mol Imaging Biol; 2016 Dec; 18(6):870-876. PubMed ID: 27351762
[TBL] [Abstract][Full Text] [Related]
29. Efficient and Targeted siRNA Delivery to M2 Macrophages by Smart Polymer Blends for M1 Macrophage Repolarization as a Promising Strategy for Future Cancer Treatment.
Jürgens DC; Winkeljann B; Kolog Gulko M; Jin Y; Möller J; Winkeljann J; Sheshachala S; Anger A; Hörner A; Adams NBP; Urbanetz N; Merkel OM
ACS Biomater Sci Eng; 2024 Jan; 10(1):166-177. PubMed ID: 37978912
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging of tumor-associated-macrophages (TAMs) with a nanoparticle contrast agent.
Zhou J; Meli VS; Yu-Tin Chen E; Kapre R; Nagalla R; Xiao W; Borowsky AD; Lam KS; Liu WF; Louie AY
RSC Adv; 2022 Mar; 12(13):7742-7756. PubMed ID: 35424752
[TBL] [Abstract][Full Text] [Related]
31. MR imaging and targeting of a specific alveolar macrophage subpopulation in LPS-induced COPD animal model using antibody-conjugated magnetic nanoparticles.
Al Faraj A; Shaik AS; Afzal S; Al Sayed B; Halwani R
Int J Nanomedicine; 2014; 9():1491-503. PubMed ID: 24711699
[TBL] [Abstract][Full Text] [Related]
32. Iron oxide nanoparticle targeting mechanism and its application in tumor magnetic resonance imaging and therapy.
Wu L; Wang C; Li Y
Nanomedicine (Lond); 2022 Sep; 17(21):1567-1583. PubMed ID: 36458585
[TBL] [Abstract][Full Text] [Related]
33. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
34. Mushroom Carboxymethylated β-d-Glucan Functions as a Macrophage-Targeting Carrier for Iron Oxide Nanoparticles and an Inducer of Proinflammatory Macrophage Polarization for Immunotherapy.
Su Y; Yang F; Chen L; Cheung PCK
J Agric Food Chem; 2022 Jun; 70(23):7110-7121. PubMed ID: 35652418
[TBL] [Abstract][Full Text] [Related]
35. [Development of Molecular Probes Based on Iron Oxide Nanoparticles for in Vivo Magnetic Resonance/Photoacoustic Dual Imaging of Target Molecules in Tumors].
Sano K
Yakugaku Zasshi; 2017; 137(1):55-60. PubMed ID: 28049896
[TBL] [Abstract][Full Text] [Related]
36. Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model.
Lee C; Bae SS; Joo H; Bae H
Oncotarget; 2017 Aug; 8(33):54951-54965. PubMed ID: 28903394
[TBL] [Abstract][Full Text] [Related]
37. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI.
Girard OM; Ramirez R; McCarty S; Mattrey RF
Contrast Media Mol Imaging; 2012; 7(4):411-7. PubMed ID: 22649047
[TBL] [Abstract][Full Text] [Related]
38. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
39. Leveraging Nanodrug Delivery System for Simultaneously Targeting Tumor Cells and M2 Tumor-Associated Macrophages for Efficient Colon Cancer Therapy.
Zeng J; Sun Y; Sun S; Jiang M; Zhang D; Li W; Liu Z; Shang H; Guan X; Zhang W
ACS Appl Mater Interfaces; 2022 Nov; 14(45):50475-50484. PubMed ID: 36327132
[TBL] [Abstract][Full Text] [Related]
40. Targeted Imaging of Tumor-Associated Macrophages by Cyanine 7-Labeled Mannose in Xenograft Tumors.
Jiang C; Cai H; Peng X; Zhang P; Wu X; Tian R
Mol Imaging; 2017 Jan; 16():1536012116689499. PubMed ID: 28654380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
